Skip to main content
Clinical Trials/NCT05236803
NCT05236803
Recruiting
N/A

Better Understand Motor Deficits Associated With Autism Spectrum Disorders: Development of an Assessment Protocol

Centre Hospitalier Charles Perrens, Bordeaux4 sites in 1 country110 target enrollmentFebruary 7, 2022

Overview

Phase
N/A
Intervention
Testing of general motor skills, fine motor skills and occulomotricity
Conditions
Autism Spectrum Disorder
Sponsor
Centre Hospitalier Charles Perrens, Bordeaux
Enrollment
110
Locations
4
Primary Endpoint
Measurement of oculomotricity with eye-tracking system (visual orientation and control)
Status
Recruiting
Last Updated
last month

Overview

Brief Summary

This research is a case-control study aiming to characterize motor peculiarities (objective quantitative and qualitative measures) and its psycho-physiological correlates of children with ASD.

Detailed Description

The main objective is to measure jointly and in an automated and standardized manner the performance and motor patterns within the framework of tasks measuring the performance and patterns of general motor skills (postures, walking, coordination overall), fine motor skills (graphics, pointing task) and oculomotricity (visual orientation and control). The secondary objective is to investigate the relationships between motor difficulties and cognitive and social disorders found in children with ASD. * Compare the motor performance data in the 3 major motor domains with each other (overall, fine and oculomotor); * Evaluate intergroup differences based on clinical characteristics (ADOS-2, ADI-R, CARS 2 scores), age, IQ, socio-communication profile score (SRS-2) and presence comorbidities (TADH, TDC).

Registry
clinicaltrials.gov
Start Date
February 7, 2022
End Date
March 31, 2027
Last Updated
last month
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Centre Hospitalier Charles Perrens, Bordeaux
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All participants :
  • Be between 6 and 11 years old
  • Mastery of the French language
  • Be affiliated with a Social Security scheme or benefit from affiliation by a third person
  • Both parents (or the holder of legal authority) have read, understood and signed the study consent
  • Be affiliated with social security
  • Participants with ASD should also verify the following inclusion criteria:
  • Being diagnosed with ASD (DSM-V)

Exclusion Criteria

  • All participants :
  • Refusal to participate in the research on the part of the participant and / or holders of parental authority.
  • Be a person benefiting from enhanced protection, namely : persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social establishment.
  • Have uncorrected visual or hearing problems
  • To have concomitant psychotropic drug treatments not stabilized, initiated in the last 2 months: antipsychotics, mood stabilizers, anti-epileptics, psychostimulants, antidepressants.
  • Have a motor handicap of the upper or lower limbs, fitted or not.
  • Have diagnosed neurological or psychiatric disorders, present a general or metabolic pathology having a known impact on the child's motor skills (eg: Epilepsy, Tics and Gilles de la Tourette Syndrome, Intellectual Deficiency, Neuromuscular Syndrome, Metabolic Neurological Syndrome , neoplasms)
  • Suspicion of low intellectual efficiency if at least one of the two subtests (Similarities or Matrices) of WISC V (retrieved from the medical file if the TSA participant) presents a result (standard score) strictly lower than
  • Participants without ASD :
  • Participant with ADHD (Attention Deficit Disorder with or without Hyperactivity) or CDD (Developmental Coordination Disorder)

Arms & Interventions

Epidemiology

Recording of participant's performance during eye, fine motor and gross motor tests Passing self and hetero questionnaires.

Intervention: Testing of general motor skills, fine motor skills and occulomotricity

Epidemiology

Recording of participant's performance during eye, fine motor and gross motor tests Passing self and hetero questionnaires.

Intervention: Questionnaires

Outcomes

Primary Outcomes

Measurement of oculomotricity with eye-tracking system (visual orientation and control)

Time Frame: At 3 month

Jointly and in an automated and standardized manner, motor patterns in the context of tasks measuring the performance and patterns of general motor skills (postures, walking, overall coordination), fine motor skills (graphics, pointing task) and oculomotricity (visual orientation and control).

Measurement performance of fine motor skills (graphics, pointing task)

Time Frame: At 3 month

Jointly and in an automated and standardized manner, measure performance in the context of tasks measuring the performance and patterns of general motor skills (postures, walking, overall coordination), fine motor skills (graphics, pointing task) and oculomotricity (visual orientation and control).

Measurement performance of general motor skills with biomechanical analysis

Time Frame: At 3 month

Jointly and in an automated and standardized manner, measure motor patterns in the context of tasks measuring the performance and patterns of general motor skills (postures, walking, overall coordination), fine motor skills (graphics, pointing task) and oculomotricity (visual orientation and control).

Secondary Outcomes

  • Score of socio-communicative skills as assessed using Social Responsiveness Scale(At visit 1 and visit 2, an average of 3 months)
  • Motor performance : success, error rate (%)(At visit 1 and visit 2, an average of 3 months)
  • Motor performance : task duration (ms), reaction time (ms) and latency (ms)(At visit 1 and visit 2, an average of 3 months)
  • IQ as assessed using WISC IV(At visit 1 and visit 2, an average of 3 months)
  • ADHD as assessed using Conners-3(At visit 1 and visit 2, an average of 3 months)
  • Developmental Coordination Disorder as assessed using Developmental Coordination Disorder Questionnaire(At visit 1 and visit 2, an average of 3 months)
  • ASD Clinical Assessment as assessed using Childhood Autism Rating Scale(At visit 1 and visit 2, an average of 3 months)

Study Sites (4)

Loading locations...

Similar Trials